We are live on ! Find out more
BWLSA

Blue Water Life Science Advisors Portfolio holdings

AUM $159M
1-Year Est. Return 139.66%
This Fund
S&P 500
This Quarter Est. Return
-0.23%
1 Year Est. Return
+139.66%
3 Year Est. Return
+503.09%
5 Year Est. Return
+228.74%
10 Year Est. Return
–
AUM
$125M
AUM Growth
-$34.6M
Cap. Flow
-$21.7M
Cap. Flow %
-17.39%
Top 10 Hldgs %
100%
Holding
11
New
2
Increased
3
Reduced
4
Closed
1

Top Buys

Rank Stock Value
1
TXG icon
10x Genomics
TXG
+$21.8M
2
CDNA icon
CareDx
CDNA
+$8.04M
3
TEM
Tempus AI
TEM
+$3.98M
4
BLLN
BillionToOne Inc
BLLN
+$1.64M
5
QTRX icon
Quanterix
QTRX
+$292K

Top Sells

Rank Stock Value
1
NTRA icon
Natera
NTRA
+$20.8M
2
ADPT icon
Adaptive Biotechnologies
ADPT
+$12M
3
GH icon
Guardant Health
GH
+$11.3M
4
GRAL
GRAIL Inc
GRAL
+$8.47M
5
TWST icon
Twist Bioscience
TWST
+$4.8M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TXG icon
1
10x Genomics
TXG
$8.1B
$23.1M 18.56%
+1,090,000
New +$21.8M
GH icon
2
Guardant Health
GH
$21.9B
$22.4M 17.94%
242,247
-112,800
-32% -$11.3M
CDNA icon
3
CareDx
CDNA
$2.41B
$16.2M 13.02%
935,000
+425,000
+83% +$8.04M
ADPT icon
4
Adaptive Biotechnologies
ADPT
$4.07B
$14M 11.24%
1,010,145
-755,000
-43% -$12M
TWST icon
5
Twist Bioscience
TWST
$8.93B
$13.1M 10.52%
276,000
-107,000
-28% -$4.8M
PSNL icon
6
Personalis
PSNL
$1.69B
$10.7M 8.56%
1,676,300
– –
NTRA icon
7
Natera
NTRA
$46.9B
$8.96M 7.18%
44,794
-96,700
-68% -$20.8M
QTRX icon
8
Quanterix
QTRX
$140M
$7.54M 6.05%
2,142,147
+50,000
+2% +$292K
TEM
9
Tempus AI
TEM
$11.1B
$7.07M 5.67%
156,412
+70,000
+81% +$3.98M
BLLN
10
BillionToOne Inc
BLLN
$4.33B
$1.58M 1.27%
+20,000
New +$1.64M
GRAL
11
GRAIL Inc
GRAL
$3.3B
– –
-99,000
Closed -$8.47M

Similar funds

SFC
Swisher Financial Concepts Westerville, Ohio $159M AUM 23.09% 1-Year Est. Return
ACP
Argyle Capital Partners Los Angeles, California $159M AUM 21.07% 1-Year Est. Return
CW
Cooksen Wealth The Woodlands, Texas $159M AUM 23.21% 1-Year Est. Return
SG
Stanich Group Montauk, New York $159M AUM 24.04% 1-Year Est. Return
LA
Lakeside Advisors Seattle, Washington $159M AUM 11.13% 1-Year Est. Return
CMMS
Comprehensive Money Management Services Coral Gables, Florida $159M AUM 18.94% 1-Year Est. Return
JWM
JP Wealth Management Mt. Pleasant, South Carolina $159M AUM 19.83% 1-Year Est. Return
AC
Agman Capital Omaha, Nebraska $159M AUM

Blue Water Life Science Advisors's Q1 2026 Portfolio in Review

As of Q1 2026, Blue Water Life Science Advisors held 11 positions worth $125M, down 22% from $159M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Blue Water Life Science Advisors withdrew a net $21.7M in Q1 2026, closing 1 position and reducing 4 holdings. Its most notable exit was GRAIL Inc, an estimated $8.47M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

Against the trend, Blue Water Life Science Advisors opened a new position in 10x Genomics worth $23.1M.

  • Blue Water Life Science Advisors's largest Q1 2026 buy was 10x Genomics: 1,090,000 shares worth $23.1M.
  • Blue Water Life Science Advisors added most to CareDx in Q1 2026, an estimated $8.04M increase.
  • Blue Water Life Science Advisors's biggest Q1 2026 reduction was Natera, cutting an estimated $20.8M.
  • Blue Water Life Science Advisors fully exited GRAIL Inc in Q1 2026, selling an estimated $8.47M.
  • Blue Water Life Science Advisors's ten largest holdings make up 100% of its $125M portfolio in Q1 2026.
  • Blue Water Life Science Advisors opened 2 new positions and closed 1 in Q1 2026.
  • Blue Water Life Science Advisors's portfolio value fell 22% quarter-over-quarter to $125M.

Based on Blue Water Life Science Advisors's 13F filing for Q1 2026, filed 14 May 2026.